Annual Total Assets
$490.42 M
-$26.54 M-5.13%
December 31, 2024
Summary
- As of March 8, 2025, BCRX annual total assets is $490.42 million, with the most recent change of -$26.54 million (-5.13%) on December 31, 2024.
- During the last 3 years, BCRX annual total assets has fallen by -$97.73 million (-16.62%).
- BCRX annual total assets is now -16.62% below its all-time high of $588.15 million, reached on December 31, 2021.
Performance
BCRX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$490.42 M
-$834.00 K-0.17%
December 31, 2024
Summary
- As of March 8, 2025, BCRX quarterly total assets is $490.42 million, with the most recent change of -$834.00 thousand (-0.17%) on December 31, 2024.
- Over the past year, BCRX quarterly total assets has dropped by -$26.54 million (-5.13%).
- BCRX quarterly total assets is now -16.62% below its all-time high of $588.15 million, reached on December 31, 2021.
Performance
BCRX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
BCRX Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.1% | -5.1% |
| 3 y3 years | -16.6% | -16.6% |
| 5 y5 years | +179.8% | +179.8% |
BCRX Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | at low | -16.6% | +4.8% |
| 5 y | 5-year | -16.6% | +179.8% | -16.6% | +259.1% |
| alltime | all time | -16.6% | +3731.4% | -16.6% | +4955.9% |
BioCryst Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $490.42 M(-5.1%) | $490.42 M(-0.2%) |
| Sep 2024 | - | $491.25 M(+4.0%) |
| Jun 2024 | - | $472.42 M(+1.0%) |
| Mar 2024 | - | $467.89 M(-9.5%) |
| Dec 2023 | $516.96 M(-6.0%) | $516.96 M(-1.1%) |
| Sep 2023 | - | $522.92 M(-1.3%) |
| Jun 2023 | - | $529.88 M(+4.0%) |
| Mar 2023 | - | $509.74 M(-7.3%) |
| Dec 2022 | $550.00 M(-6.5%) | $550.00 M(-1.5%) |
| Sep 2022 | - | $558.59 M(+9.4%) |
| Jun 2022 | - | $510.54 M(-3.3%) |
| Mar 2022 | - | $527.72 M(-10.3%) |
| Dec 2021 | $588.15 M(+75.7%) | $588.15 M(+121.3%) |
| Sep 2021 | - | $265.76 M(-4.2%) |
| Jun 2021 | - | $277.28 M(-2.5%) |
| Mar 2021 | - | $284.43 M(-15.0%) |
| Dec 2020 | $334.71 M(+91.0%) | $334.71 M(+89.9%) |
| Sep 2020 | - | $176.23 M(-17.9%) |
| Jun 2020 | - | $214.71 M(+57.2%) |
| Mar 2020 | - | $136.59 M(-22.1%) |
| Dec 2019 | $175.28 M(+19.4%) | $175.28 M(+93.7%) |
| Sep 2019 | - | $90.50 M(-22.2%) |
| Jun 2019 | - | $116.34 M(-18.3%) |
| Mar 2019 | - | $142.34 M(-3.1%) |
| Dec 2018 | $146.84 M(-17.6%) | $146.84 M(-12.8%) |
| Sep 2018 | - | $168.31 M(+23.2%) |
| Jun 2018 | - | $136.64 M(-12.1%) |
| Mar 2018 | - | $155.37 M(-12.8%) |
| Dec 2017 | $178.26 M(+98.4%) | $178.26 M(-6.9%) |
| Sep 2017 | - | $191.49 M(+68.7%) |
| Jun 2017 | - | $113.51 M(-12.4%) |
| Mar 2017 | - | $129.51 M(+44.1%) |
| Dec 2016 | $89.85 M(-26.6%) | $89.85 M(-1.8%) |
| Sep 2016 | - | $91.50 M(+11.3%) |
| Jun 2016 | - | $82.22 M(-20.1%) |
| Mar 2016 | - | $102.88 M(-15.9%) |
| Dec 2015 | $122.36 M(-10.6%) | $122.36 M(-11.9%) |
| Sep 2015 | - | $138.96 M(-7.5%) |
| Jun 2015 | - | $150.18 M(+15.6%) |
| Mar 2015 | - | $129.87 M(-5.1%) |
| Dec 2014 | $136.87 M(+180.1%) | $136.87 M(-0.2%) |
| Sep 2014 | - | $137.13 M(-3.4%) |
| Jun 2014 | - | $141.97 M(+227.2%) |
| Mar 2014 | - | $43.39 M(-11.2%) |
| Dec 2013 | $48.87 M(-14.9%) | $48.87 M(-8.2%) |
| Sep 2013 | - | $53.20 M(+33.3%) |
| Jun 2013 | - | $39.92 M(-14.9%) |
| Mar 2013 | - | $46.90 M(-18.3%) |
| Dec 2012 | $57.44 M(-30.1%) | $57.44 M(-10.4%) |
| Sep 2012 | - | $64.09 M(-15.9%) |
| Jun 2012 | - | $76.24 M(-4.8%) |
| Mar 2012 | - | $80.08 M(-2.6%) |
| Dec 2011 | $82.21 M(-24.9%) | $82.21 M(-11.1%) |
| Sep 2011 | - | $92.51 M(-14.7%) |
| Jun 2011 | - | $108.41 M(-11.7%) |
| Mar 2011 | - | $122.77 M(+12.2%) |
| Dec 2010 | $109.45 M(-23.0%) | $109.45 M(-1.7%) |
| Sep 2010 | - | $111.35 M(-4.1%) |
| Jun 2010 | - | $116.10 M(-6.9%) |
| Mar 2010 | - | $124.66 M(-12.3%) |
| Dec 2009 | $142.19 M | $142.19 M(+134.7%) |
| Sep 2009 | - | $60.59 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | $64.69 M(-10.9%) |
| Mar 2009 | - | $72.60 M(-14.3%) |
| Dec 2008 | $84.69 M(-40.7%) | $84.69 M(-14.8%) |
| Sep 2008 | - | $99.35 M(-7.7%) |
| Jun 2008 | - | $107.65 M(-16.6%) |
| Mar 2008 | - | $129.14 M(-9.5%) |
| Dec 2007 | $142.72 M(+108.4%) | $142.72 M(+1.1%) |
| Sep 2007 | - | $141.15 M(+80.0%) |
| Jun 2007 | - | $78.43 M(+15.5%) |
| Mar 2007 | - | $67.92 M(-0.8%) |
| Dec 2006 | $68.49 M(-31.0%) | $68.49 M(-14.6%) |
| Sep 2006 | - | $80.20 M(-12.7%) |
| Jun 2006 | - | $91.88 M(-10.1%) |
| Mar 2006 | - | $102.22 M(+3.0%) |
| Dec 2005 | $99.25 M(+205.7%) | $99.25 M(+160.1%) |
| Sep 2005 | - | $38.15 M(-12.1%) |
| Jun 2005 | - | $43.42 M(-12.3%) |
| Mar 2005 | - | $49.49 M(+52.4%) |
| Dec 2004 | $32.47 M(+7.9%) | $32.47 M(-14.3%) |
| Sep 2004 | - | $37.88 M(-9.3%) |
| Jun 2004 | - | $41.77 M(-9.1%) |
| Mar 2004 | - | $45.95 M(+52.7%) |
| Dec 2003 | $30.10 M(-27.1%) | $30.10 M(-6.6%) |
| Sep 2003 | - | $32.24 M(-9.8%) |
| Jun 2003 | - | $35.74 M(-7.3%) |
| Mar 2003 | - | $38.56 M(-6.6%) |
| Dec 2002 | $41.30 M(-30.1%) | $41.30 M(-6.3%) |
| Sep 2002 | - | $44.09 M(-7.9%) |
| Jun 2002 | - | $47.88 M(-10.0%) |
| Mar 2002 | - | $53.17 M(-10.0%) |
| Dec 2001 | $59.10 M(-16.6%) | $59.10 M(-6.0%) |
| Sep 2001 | - | $62.85 M(-4.1%) |
| Jun 2001 | - | $65.55 M(-3.7%) |
| Mar 2001 | - | $68.07 M(-3.9%) |
| Dec 2000 | $70.83 M(-3.5%) | $70.83 M(-2.1%) |
| Sep 2000 | - | $72.38 M(-2.7%) |
| Jun 2000 | - | $74.38 M(-1.9%) |
| Mar 2000 | - | $75.83 M(+3.3%) |
| Dec 1999 | $73.40 M(+152.2%) | $73.40 M(+178.0%) |
| Sep 1999 | - | $26.40 M(-0.4%) |
| Jun 1999 | - | $26.50 M(-0.7%) |
| Mar 1999 | - | $26.70 M(-8.2%) |
| Dec 1998 | $29.10 M(+9.8%) | $29.10 M(+18.8%) |
| Sep 1998 | - | $24.50 M(+15.0%) |
| Jun 1998 | - | $21.30 M(-13.1%) |
| Mar 1998 | - | $24.50 M(-7.5%) |
| Dec 1997 | $26.50 M(-28.6%) | $26.50 M(-10.8%) |
| Sep 1997 | - | $29.70 M(-8.0%) |
| Jun 1997 | - | $32.30 M(-5.6%) |
| Mar 1997 | - | $34.20 M(-7.8%) |
| Dec 1996 | $37.10 M(+183.2%) | $37.10 M(+4.8%) |
| Sep 1996 | - | $35.40 M(+79.7%) |
| Jun 1996 | - | $19.70 M(+3.1%) |
| Mar 1996 | - | $19.10 M(+45.8%) |
| Dec 1995 | $13.10 M(+2.3%) | $13.10 M(-11.5%) |
| Sep 1995 | - | $14.80 M(-12.4%) |
| Jun 1995 | - | $16.90 M(+74.2%) |
| Mar 1995 | - | $9.70 M(-24.2%) |
| Dec 1994 | $12.80 M | $12.80 M(-12.9%) |
| Sep 1994 | - | $14.70 M(-2.0%) |
| Jun 1994 | - | $15.00 M(-12.3%) |
| Mar 1994 | - | $17.10 M |
FAQ
- What is BioCryst Pharmaceuticals annual total assets?
- What is the all time high annual total assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual total assets year-on-year change?
- What is BioCryst Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly total assets year-on-year change?
What is BioCryst Pharmaceuticals annual total assets?
The current annual total assets of BCRX is $490.42 M
What is the all time high annual total assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual total assets is $588.15 M
What is BioCryst Pharmaceuticals annual total assets year-on-year change?
Over the past year, BCRX annual total assets has changed by -$26.54 M (-5.13%)
What is BioCryst Pharmaceuticals quarterly total assets?
The current quarterly total assets of BCRX is $490.42 M
What is the all time high quarterly total assets for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly total assets is $588.15 M
What is BioCryst Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, BCRX quarterly total assets has changed by -$26.54 M (-5.13%)